{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:09Z","timestamp":1781629509297,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473414, 82141121"],"award-info":[{"award-number":["82473414, 82141121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["Y-MSDPU2021-0223, Y-QL2019-0364"],"award-info":[{"award-number":["Y-MSDPU2021-0223, Y-QL2019-0364"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bethune Young and middle aged Scientific Research training project","award":["BQE-TY-SSPC(2)-N-01"],"award-info":[{"award-number":["BQE-TY-SSPC(2)-N-01"]}]},{"name":"Scientific research project of Ili Prefecture Clinical Research Institute","award":["yl2020ms11"],"award-info":[{"award-number":["yl2020ms11"]}]},{"name":"Jiangsu Province\u2019s Key provincial Talents Program","award":["ZDRCA2016028"],"award-info":[{"award-number":["ZDRCA2016028"]}]},{"name":"Open Project of Jiangsu Biobank of Clinical Resources","award":["SBK202004003"],"award-info":[{"award-number":["SBK202004003"]}]},{"name":"Specialized Diseases Clinical Research Fund of Jiangsu Province Hospital","award":["DL202412"],"award-info":[{"award-number":["DL202412"]}]},{"name":"Joint Open Research Fund of Nanjing University of Posts and Telecommunications & Jiangsu Province Hospital"},{"name":"Medical Engineering Translational Fund of Jiangsu Province Hospital","award":["RG202401"],"award-info":[{"award-number":["RG202401"]}]},{"name":"the Friendship Hospital of Ili Kazakh Autonomous Prefecture, Ili & Jiangsu Joint Institute of Health","award":["yl2023zd02, yl2024ms12"],"award-info":[{"award-number":["yl2023zd02, yl2024ms12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with thymic epithelial tumors (TETs) frequently show coexistence of various paraneoplastic syndromes, which severely affect their survival. Moreover, there is a lack of effective clinical treatment strategies for patients with unresectable metastatic and recurrent TETs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To explore the genetic alterations that play a key role in the pathogenesis of TETs, we analyzed the whole-exome sequencing data from 24 patients diagnosed to have TETs at the First Affiliated Hospital of Nanjing Medical University.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mutated genes in TETs were enriched in several hormone-associated pathways such as insulin secretion; Cushing syndrome; parathyroid hormone; and thyroid hormone, as well as multiple classical tumor-associated pathways, including cAMP, Notch, PI3K-Akt, and WNT signaling pathway. Patients with paraneoplastic syndromes (PNS) exhibited more pronounced alterations in hormone-related pathways.\n                      <jats:italic>RHPN2<\/jats:italic>\n                      is the most frequently mutated gene in TETs. TETs with\n                      <jats:italic>RHPN2<\/jats:italic>\n                      mutation showed greater upregulation of the hormone-related signaling pathways such as thyroid hormone and parathyroid hormone as well as a trend toward shorter survival of patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We analyzed the possible role of hormones in TETs on several levels, explored potential links between hormones and other genetic mutations, and found that\n                      <jats:italic>RHPN2<\/jats:italic>\n                      may be a potentially valuable gene.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15455-4","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:47:35Z","timestamp":1765536455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic alterations and aberrant hormonal pathways in thymic epithelial tumors"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"15455_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"deJong WK, Blaauwgeers JLG, Schaapveld M, et al. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer. 2008;44:123\u201330. https:\/\/doi.org\/10.1016\/j.ejca.2007.11.004.","journal-title":"Eur J Cancer"},{"key":"15455_CR2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/life13051170","volume":"13","author":"A Tartarone","year":"2023","unstructured":"TartaroneA, Lerose R, Lettini AR, Tartarone M. Current treatment approaches for thymic epithelial tumors. Life (Basel). 2023;13:1170. https:\/\/doi.org\/10.3390\/life13051170.","journal-title":"Life (Basel)"},{"key":"15455_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.21037\/jtd.2016.03.23","volume":"8","author":"W Fang","year":"2016","unstructured":"Fang W, Fu J, Shen Y, et al. Management of thymic tumors-consensus based on the Chinese alliance for research in thymomas Multi-institutional retrospective studies. J Thorac Dis. 2016;8:641\u20135. https:\/\/doi.org\/10.21037\/jtd.2016.03.23.","journal-title":"J Thorac Dis"},{"key":"15455_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/med-23-47","volume":"8","author":"L Cabez\u00f3n-Guti\u00e9rrez","year":"2024","unstructured":"Cabez\u00f3n-Guti\u00e9rrez L, Pacheco-Barcia V, Carrasco-Valero F, et al. Update on thymic epithelial tumors: a narrative review. Mediastinum. 2024;8:33. https:\/\/doi.org\/10.21037\/med-23-47.","journal-title":"Mediastinum"},{"key":"15455_CR5","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1530\/ERC-17-0036","volume":"24","author":"GK Dimitriadis","year":"2017","unstructured":"Dimitriadis GK, Angelousi A, Weickert MO, et al. Paraneoplastic endocrine syndromes. Endocr Relat Cancer. 2017;24:R173\u201390. https:\/\/doi.org\/10.1530\/ERC-17-0036.","journal-title":"Endocr Relat Cancer"},{"key":"15455_CR6","doi-asserted-by":"publisher","first-page":"103676","DOI":"10.1016\/j.critrevonc.2022.103676","volume":"174","author":"C Sardi\u00f1a Gonz\u00e1lez","year":"2022","unstructured":"Sardi\u00f1a Gonz\u00e1lez C, Mart\u00ednez Vivero C, L\u00f3pez Castro J. Paraneoplastic syndromes review: the great forgotten ones. Crit Rev Oncol Hematol. 2022;174:103676. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103676.","journal-title":"Crit Rev Oncol Hematol"},{"key":"15455_CR7","doi-asserted-by":"publisher","unstructured":"Multidisciplinary Committee of Oncology, Chinese Physicians Association. Chinese guideline for clinical diagnosis and treatment of thymic epithelial tumors (2021 Edition). Chin J Oncol. 2021;43(04):395\u2013404. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20210313-00226.","DOI":"10.3760\/cma.j.cn112152-20210313-00226"},{"key":"15455_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","volume":"16","author":"A Thomas","year":"2015","unstructured":"Thomas A, Rajan A, Berman A, et al. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol. 2015;16:177\u201386. https:\/\/doi.org\/10.1016\/S1470-2045(14)71181-7.","journal-title":"Lancet Oncol"},{"key":"15455_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","volume":"36","author":"PA Zucali","year":"2018","unstructured":"Zucali PA, De Pas T, Palmieri G, et al. Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with Cisplatin-Based chemotherapy. J Clin Oncol. 2018;36:342\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.74.4078.","journal-title":"J Clin Oncol"},{"key":"15455_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","volume":"19","author":"G Giaccone","year":"2018","unstructured":"Giaccone G, Kim C, Thompson J, et al. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol. 2018;19:347\u201355. https:\/\/doi.org\/10.1016\/S1470-2045(18)30062-7.","journal-title":"Lancet Oncol"},{"key":"15455_CR11","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","volume":"37","author":"J Cho","year":"2019","unstructured":"Cho J, Kim HS, Ku BM, et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an Open-Label phase II trial. J Clin Oncol. 2019;37:2162\u201370. https:\/\/doi.org\/10.1200\/JCO.2017.77.3184.","journal-title":"J Clin Oncol"},{"key":"15455_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30:2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics"},{"key":"15455_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"15455_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303. https:\/\/doi.org\/10.1101\/gr.107524.110.","journal-title":"Genome Res"},{"key":"15455_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374. https:\/\/doi.org\/10.1038\/nature15393.","journal-title":"Nature"},{"key":"15455_CR16","doi-asserted-by":"publisher","first-page":"D840","DOI":"10.1093\/nar\/gkw971","volume":"45","author":"KJ Karczewski","year":"2017","unstructured":"Karczewski KJ, Weisburd B, Thomas B, et al. The ExAC browser: displaying reference data information from over 60 000 exomes. Nucleic Acids Res. 2017;45:D840\u20135. https:\/\/doi.org\/10.1093\/nar\/gkw971.","journal-title":"Nucleic Acids Res"},{"key":"15455_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","volume":"10","author":"D Sha","year":"2020","unstructured":"Sha D, Jin Z, Budczies J, et al. Tumor mutational burden as a predictive biomarker in solid tumors. Cancer Discov. 2020;10:1808\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0522.","journal-title":"Cancer Discov"},{"key":"15455_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu B, Ye K, Zhang Q, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics. 2014;30:1015\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btt755.","journal-title":"Bioinformatics"},{"key":"15455_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321. https:\/\/doi.org\/10.1038\/nature12477.","journal-title":"Nature"},{"key":"15455_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138. https:\/\/doi.org\/10.1038\/nature12213.","journal-title":"Nature"},{"key":"15455_CR21","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12:R41. https:\/\/doi.org\/10.1186\/gb-2011-12-4-r41.","journal-title":"Genome Biol"},{"key":"15455_CR22","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260.","journal-title":"Bioinformatics"},{"key":"15455_CR23","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","volume":"12","author":"TG Blum","year":"2020","unstructured":"Blum TG, Misch D, Kollmeier J, et al. Autoimmune disorders and paraneoplastic syndromes in thymoma. J Thorac Dis. 2020;12:7571\u201390. https:\/\/doi.org\/10.21037\/jtd-2019-thym-10.","journal-title":"J Thorac Dis"},{"key":"15455_CR24","doi-asserted-by":"publisher","first-page":"e13260","DOI":"10.1111\/acel.13260","volume":"19","author":"BR Gauthier","year":"2020","unstructured":"Gauthier BR, Sola-Garc\u00eda A, C\u00e1liz-Molina M\u00c1, et al. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020;19:e13260. https:\/\/doi.org\/10.1111\/acel.13260.","journal-title":"Aging Cell"},{"key":"15455_CR25","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/cancers15071982","volume":"15","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Su S, Li X. Parathyroid hormone-Related Protein\/Parathyroid hormone receptor 1 signaling in cancer and metastasis. Cancers (Basel). 2023;15:1982. https:\/\/doi.org\/10.3390\/cancers15071982.","journal-title":"Cancers (Basel)"},{"key":"15455_CR26","doi-asserted-by":"publisher","first-page":"637614","DOI":"10.3389\/fvets.2021.637614","volume":"8","author":"AA Al-Khan","year":"2021","unstructured":"Al-Khan AA, Al Balushi NR, Richardson SJ, Danks JA. Roles of parathyroid Hormone-Related protein (PTHrP) and its receptor (PTHR1) in normal and tumor tissues: focus on their roles in osteosarcoma. Front Vet Sci. 2021;8:637614. https:\/\/doi.org\/10.3389\/fvets.2021.637614.","journal-title":"Front Vet Sci"},{"key":"15455_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu Y, Liu J, et al. cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol. 2024;17:5. https:\/\/doi.org\/10.1186\/s13045-024-01524-x.","journal-title":"J Hematol Oncol"},{"key":"15455_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, et al. The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol. 2023;16:45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z.","journal-title":"J Hematol Oncol"},{"key":"15455_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"15455_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17:46. https:\/\/doi.org\/10.1186\/s13045-024-01563-4.","journal-title":"J Hematol Oncol"},{"key":"15455_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.10.022","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK. Special issue: PI3K\/Akt signaling in human cancer. Semin Cancer Biol. 2019;59:1\u20132. https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.022.","journal-title":"Semin Cancer Biol"},{"key":"15455_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK. mTOR: role in cancer, metastasis and drug resistance. Semin Cancer Biol. 2019;59:92\u2013111. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.003.","journal-title":"Semin Cancer Biol"},{"key":"15455_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40510-021-00394-0","volume":"23","author":"M Xu","year":"2022","unstructured":"Xu M, Li Y, Feng X, et al. Parathyroid hormone promotes maxillary expansion and reduces relapse in the repeated activation maxillary expansion rat model by regulating Wnt\/\u03b2-catenin pathway. Prog Orthod. 2022;23:1. https:\/\/doi.org\/10.1186\/s40510-021-00394-0.","journal-title":"Prog Orthod"},{"key":"15455_CR34","doi-asserted-by":"publisher","first-page":"725708","DOI":"10.3389\/fendo.2021.725708","volume":"12","author":"M Sirakov","year":"2021","unstructured":"Sirakov M, Claret L, Plateroti M. Thyroid hormone nuclear receptor TR\u03b11 and canonical WNT pathway Cross-Regulation in normal intestine and cancer. Front Endocrinol (Lausanne). 2021;12:725708. https:\/\/doi.org\/10.3389\/fendo.2021.725708.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"15455_CR35","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.ajpath.2020.08.006","volume":"190","author":"S Yang","year":"2020","unstructured":"Yang S, Zhang Y, Zhang Z, et al. Insulin promotes corneal nerve repair and wound healing in type 1 diabetic mice by enhancing Wnt\/\u03b2-Catenin signaling. Am J Pathol. 2020;190:2237\u201350. https:\/\/doi.org\/10.1016\/j.ajpath.2020.08.006.","journal-title":"Am J Pathol"},{"key":"15455_CR36","doi-asserted-by":"publisher","first-page":"e09271","DOI":"10.15252\/emmm.201809271","volume":"12","author":"SS Hasan","year":"2020","unstructured":"Hasan SS, Jabs M, Taylor J, et al. Endothelial Notch signaling controls insulin transport in muscle. EMBO Mol Med. 2020;12:e09271. https:\/\/doi.org\/10.15252\/emmm.201809271.","journal-title":"EMBO Mol Med"},{"key":"15455_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bone.2017.06.027","volume":"103","author":"S Zanotti","year":"2017","unstructured":"Zanotti S, Canalis E. Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes. Bone. 2017;103:159\u201367. https:\/\/doi.org\/10.1016\/j.bone.2017.06.027.","journal-title":"Bone"},{"key":"15455_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/thy.2023.0594","volume":"34","author":"H-Y Zhang","year":"2024","unstructured":"Zhang H-Y, Wu F-Y, Zhang C-X, et al. Contactin 6, A novel causative gene for congenital Hypothyroidism, mediates thyroid hormone biosynthesis through Notch signaling. Thyroid. 2024;34:324\u201335. https:\/\/doi.org\/10.1089\/thy.2023.0594.","journal-title":"Thyroid"},{"key":"15455_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12964-023-01318-7","volume":"21","author":"C Zhou","year":"2023","unstructured":"Zhou C, Guan D, Guo J, et al. Correction: Human parathyroid hormone analog (3\u201334\/29\u201334) promotes wound re-epithelialization through inducing keratinocyte migration and epithelial-mesenchymal transition via PTHR1-PI3K\/AKT activation. Cell Commun Signal. 2023;21:243. https:\/\/doi.org\/10.1186\/s12964-023-01318-7.","journal-title":"Cell Commun Signal"},{"key":"15455_CR40","doi-asserted-by":"publisher","first-page":"118977","DOI":"10.1016\/j.lfs.2020.118977","volume":"267","author":"B Zeng","year":"2021","unstructured":"Zeng B, Liao X, Liu L, et al. Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1\/PI3K\/AKT signaling pathway. Life Sci. 2021;267:118977. https:\/\/doi.org\/10.1016\/j.lfs.2020.118977.","journal-title":"Life Sci"},{"key":"15455_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1042\/BCJ20210134","volume":"479","author":"BP Leitner","year":"2022","unstructured":"Leitner BP, Siebel S, Akingbesote ND, et al. Insulin and cancer: a tangled web. Biochem J. 2022;479:583\u2013607. https:\/\/doi.org\/10.1042\/BCJ20210134.","journal-title":"Biochem J"},{"key":"15455_CR42","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.2147\/OTT.S272752","volume":"13","author":"F Yu","year":"2020","unstructured":"Yu F, Qiao P, Yin G, et al. RHPN2 promotes malignant cell behaviours in ovarian cancer by activating STAT3 signalling. Onco Targets Ther. 2020;13:11517\u201327. https:\/\/doi.org\/10.2147\/OTT.S272752.","journal-title":"Onco Targets Ther"},{"key":"15455_CR43","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1158\/0008-5472.CAN-13-1168-T","volume":"73","author":"C Danussi","year":"2013","unstructured":"Danussi C, Akavia UD, Niola F, et al. RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation. Cancer Res. 2013;73:5140\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1168-T.","journal-title":"Cancer Res"},{"key":"15455_CR44","doi-asserted-by":"publisher","unstructured":"Liu Z, Fang F, Li J, et al. RHPN2 is highly expressed in osteosarcoma cells to promote cell proliferation and migration and inhibit apoptosis. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1367\u201373. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2022.09.13.","DOI":"10.12122\/j.issn.1673-4254.2022.09.13"},{"key":"15455_CR45","doi-asserted-by":"publisher","first-page":"e179742","DOI":"10.1172\/JCI179742","volume":"134","author":"HJ Kaminski","year":"2024","unstructured":"Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Invest. 2024;134:e179742. https:\/\/doi.org\/10.1172\/JCI179742.","journal-title":"J Clin Invest"},{"key":"15455_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cei.13546","volume":"203","author":"A Uzawa","year":"2021","unstructured":"Uzawa A, Kuwabara S, Suzuki S, et al. Roles of cytokines and T cells in the pathogenesis of myasthenia Gravis. Clin Exp Immunol. 2021;203:366\u201374. https:\/\/doi.org\/10.1111\/cei.13546.","journal-title":"Clin Exp Immunol"},{"key":"15455_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00223-016-0161-3","volume":"99","author":"G Adami","year":"2016","unstructured":"Adami G, Orsolini G, Adami S, et al. Effects of TNF inhibitors on parathyroid hormone and Wnt signaling antagonists in rheumatoid arthritis. Calcif Tissue Int. 2016;99:360\u20134. https:\/\/doi.org\/10.1007\/s00223-016-0161-3.","journal-title":"Calcif Tissue Int"},{"key":"15455_CR48","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1002\/tox.24264","volume":"39","author":"S-M Chen","year":"2024","unstructured":"Chen S-M, Hsiao C-W, Chen Y-J, et al. Interleukin-4 inhibits the hypothalamic appetite control by modulating the insulin-AKT and JAK-STAT signaling in leptin mutant mice. Environ Toxicol. 2024;39:3980\u201390. https:\/\/doi.org\/10.1002\/tox.24264.","journal-title":"Environ Toxicol"},{"key":"15455_CR49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ng.879","volume":"43","author":"SE Dobbins","year":"2011","unstructured":"Dobbins SE, Broderick P, Melin B, et al. Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet. 2011;43:825\u20137. https:\/\/doi.org\/10.1038\/ng.879.","journal-title":"Nat Genet"},{"key":"15455_CR50","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.2147\/IJGM.S360177","volume":"15","author":"R Zhou","year":"2022","unstructured":"Zhou R, Zhu X, Peng Y, et al. Clinical impact of 11q13.3 amplification on immune cell infiltration and prognosis in breast cancer. Int J Gen Med. 2022;15:4037\u201352. https:\/\/doi.org\/10.2147\/IJGM.S360177.","journal-title":"Int J Gen Med"},{"key":"15455_CR51","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1158\/1541-7786.MCR-15-0169","volume":"13","author":"X-S Liu","year":"2015","unstructured":"Liu X-S, Genet MD, Haines JE, et al. ZBTB7A suppresses melanoma metastasis by transcriptionally repressing MCAM. Mol Cancer Res. 2015;13:1206\u201317. https:\/\/doi.org\/10.1158\/1541-7786.MCR-15-0169.","journal-title":"Mol Cancer Res"},{"key":"15455_CR52","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.3390\/cancers15164018","volume":"15","author":"T Tanaka","year":"2023","unstructured":"Tanaka T, Goto Y, Horie M, et al. Whole exome sequencing of thymoma patients exhibiting exceptional responses to pemetrexed monotherapy. Cancers (Basel). 2023;15:4018. https:\/\/doi.org\/10.3390\/cancers15164018.","journal-title":"Cancers (Basel)"},{"key":"15455_CR53","first-page":"2387","volume":"12","author":"X Hou","year":"2022","unstructured":"Hou X, Lin S, Liu Y, et al. Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumors. Am J Cancer Res. 2022;12:2387\u201396.","journal-title":"Am J Cancer Res"},{"key":"15455_CR54","doi-asserted-by":"publisher","first-page":"e2200465","DOI":"10.1200\/PO.22.00465","volume":"7","author":"F Ardeshir-Larijani","year":"2023","unstructured":"Ardeshir-Larijani F, Schneider BP, Althouse SK, et al. Clinicogenomic landscape of metastatic thymic epithelial tumors. JCO Precis Oncol. 2023;7:e2200465. https:\/\/doi.org\/10.1200\/PO.22.00465.","journal-title":"JCO Precis Oncol"},{"key":"15455_CR55","doi-asserted-by":"publisher","first-page":"748820","DOI":"10.3389\/fimmu.2021.748820","volume":"12","author":"W Fang","year":"2021","unstructured":"Fang W, Wu C-H, Sun Q-L, et al. Novel Tumor-Specific antigens for immunotherapy identified from Multi-omics profiling in thymic carcinomas. Front Immunol. 2021;12:748820. https:\/\/doi.org\/10.3389\/fimmu.2021.748820.","journal-title":"Front Immunol"},{"key":"15455_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00428-023-03536-3","volume":"482","author":"J Li","year":"2023","unstructured":"Li J, Xiang R, Li Y, et al. Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis. Virchows Arch. 2023;482:813\u201322. https:\/\/doi.org\/10.1007\/s00428-023-03536-3.","journal-title":"Virchows Arch"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15455-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:27:30Z","timestamp":1781627250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15455-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15455"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15455-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient data were collected after obtaining written informed consent from all patients. The study protocol was approved by the institutional review board of the First Affiliated Hospital of Nanjing Medical University (Approval No. 2025-SR-496).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}